Sign in
Not yet recruitingNo phase

Efficacy Analysis of Saccharomyces Boulardii Combined With Minocycline in Treatment-naïve Patients With Helicobacter Pylori Infection

Key facts

Who runs it
Zhongda Hospital
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
208 people, planned
Started
Jun 2025
Planned end
Dec 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Bismuth quadruple therapy
  • Saccharomyces boulardii
Record updated
10 June 2025

Who can take part

Age
18 years to 70 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Aged 18-70 years, regardless of gender
  • Positive 13C/14C urea breath test result
  • No previous history of H. pylori eradication treatment
  • Agreement to participate in this study and signing of the informed consent form

Who cannot take part

  • History of ≥ 1 instance of failed H. pylori eradication
  • Severe liver, kidney, or cardiovascular diseases; malignancies; and alcoholism
  • Allergies to the drugs used in this study or a history of penicillin allergy
  • The inability to correctly express one's symptoms and wishes, such as inability due to mental illness or severe neurosis
  • Use of antibiotics (including antibacterial traditional Chinese medicines), nonsteroidal anti-inflammatory drugs (NSAIDS), bismuth agents, H2 receptor antagonists (H2RAs), proton-pump inhibitors (PPIs), and potassium-competitive acid blockers (P-CAB) within 4 weeks before treatment
  • Plans to conceive, pregnancy, or breastfeeding

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 70 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

To assess the efficacy and safety of Saccharomyces boulardii combined with triple therapy containing minocycline in the initial eradication of Helicobacter pylori (H. pylori) infection

The 2 groups in the trial

  • Control GroupExisting treatment, for comparison

    Treatment: Bismuth quadruple therapy

  • Experimental groupTreatment being tested

    Treatment: Saccharomyces boulardii

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT07012785, who can take part
Record updated
10 June 2025